DAYTON — Hospice of Dayton has been named one of a limited number of Medicare-certified hospice providers across the country to participate in the new Medicare Care Choices Model. The Centers for Medicare & Medicaid Services (CMS) plans to launch of the “concurrent care” demonstration authorized by the Patient Protection and Affordable Care Act (PPACA) in 2016.
Hospice of Dayton, along with other hospices selected for the pilot, will provide palliative support services in the form of routine home care and in-home respite to patients with advanced cancers, chronic obstructive pulmonary disease, congestive heart failure and HIV/AIDS who meet hospice eligibility requirements. The patients will have the option to also receive services provided by their curative care providers at the same time. Hospices selected for the three-year demonstration will receive $400 per beneficiary per month (PBPM) to provide the palliative care services.
Hospices selected for the project must be Medicare-certified hospice and able to demonstrate experience providing care coordination and/or case management with a network of various types of healthcare providers, as well as shared decision-making to beneficiaries prior to electing the Medicare hospice benefit in conjunction with their referring providers/suppliers.
Recognized nationally for innovation in hospice care, Hospice of Dayton already offers a greater range of services than competitors reflecting the goals of the concurrent care demonstration. Initially offering only palliative radiation and palliative chemotherapy along with hospice services, Hospice of Dayton’s program first focused on improving an oncology patient’s level of comfort. Due to increasing numbers of patients with advanced chronic illness, the program has expanded to cover additional palliative treatments unrelated to oncology.
Today, Hospice of Dayton provides concurrent care to patients with chronic heart failure, chronic obstructive pulmonary disease, and pulmonary hypertension. In addition to differentiating the organization from competitors in the market, the expanding concurrent care program is aligned with the mission to focus on inclusionary—rather than exclusionary—practices of patient access and delivery of superior end-of-life care.
According to Hospice of Dayton Vice President of Mission Support Kim Vesey, the Care Choice option will greatly benefit patients. “Patients with a terminal diagnosis who wish to continue with aggressive treatments will have the option to do so. They will also receive the opportunity to benefit from the holistic, interdisciplinary care provided by the hospice team. Family caregivers will also have the support from the hospice team that is a hallmark of the hospice model of care. We believe that the Medicare Care Choices Model project will validate that patients who have access to hospice alongside curative care have better outcomes, higher family caregiver satisfaction, and benefit from the expertise of hospice earlier in their care.”